Display Settings:

Format

Send to:

Choose Destination
Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease.

Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease.

National Clinical Guideline Centre (UK).

London: National Institute for Health and Care Excellence (UK); 2014 Jul. (NICE Clinical Guidelines, No. 181.)

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center